NASDAQ
Kalaris Therapeutics Inc (KLRS) has a current ratio of 12.23x as of Monday, May 25, 2026. This represents a 58.58% increase compared to its 12-month average of 7.71x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.